Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Related Keywords

France ,Switzerland ,French ,Swiss , ,Novartis ,Astrazeneca ,United Kingdom Listed ,Jefferies ,Upgrades ,39 Buy 039 ,Cuts ,39 Hold 039 ,Category All ,Category Broker Recommendations ,Category Sectorial Health Technology ,